Feedback / Questions
BOLD-100 - Bold Therap
ceralasertib (AZD6738) - AstraZeneca
https://www.prnewswire.com/news-releases/bold-100-and-atr-inhibitors-as-a-new-avenue-for-pdac-targeting-at-aacr-2024-302108994.html
Apr 5, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next